Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

被引：11

作者：

Garcia-Manero, Guillermo ^{[1
]}

Fenaux, Pierre ^{[2
]}

Al-Kali, Aref ^{[3
]}

Navada, Shyamala C. ^{[4
]}

Baer, Maria R. ^{[5
]}

Raza, Azra ^{[6
]}

Greenberg, Peter ^{[7
]}

Kreuzer, Karl-Anton ^{[8
]}

Hiwase, Devendra K. ^{[9
]}

Roboz, Gail J. ^{[10
,11
]}

Santini, Valeria ^{[12
]}

Platzbecker, Uwe ^{[13
]}

Petrone, Michael E. ^{[14
]}

Brownstein, Bernard ^{[14
]}

Zbyszewski, Patrick Simon ^{[14
]}

Maniar, Manoj ^{[14
]}

Silverman, Lewis R. ^{[4
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Paris, Hop St Louis, Paris, France

[3] Mayo Clin, Rochester, MN USA

[4] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA

[5] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[6] Columbia Univ, Med Ctr, New York, NY 10025 USA

[7] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA

[8] Univ Cologne, Clin Internal Med, Cologne, Germany

[9] Royal Adelaide Hosp, Haematol, Adelaide, SA, Australia

[10] Weill Cornell Med, Div Hematol & Oncol, New York, NY USA

[11] New York Presbyterian Hosp, New York, NY USA

[12] Univ Florence, Div Hematol, Florence, Italy

[13] Univ Hosp Carl Gustav Carus, Dresden, Germany

[14] Onconova Therapeut Inc, Newtown, PA USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.100.100

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2011

引用

页数：6

共 50 条

[1] A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML)
Navada, S. C.
Garcia-Manero, G.
Hearn, K.
Odchimar-Reissig, R.
Demakos, E.
Alvarado, Y.
Daver, N.
DiNardo, C.
Konopleva, M.
Borthakur, G.
Azarnia, N.
Silverman, L. R.
[J]. LEUKEMIA RESEARCH, 2015, 39 : S45 - S45
[2] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Germing, Ulrich
Haferlach, Torsten
[J]. LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
[3] A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia
Navada, Shyamala C.
Fruchtman, Steven M.
Odchimar-Reissig, Rosalie
Demakos, Erin P.
Petrone, Michael E.
Zbyszewski, Patrick S.
Holland, James F.
Silverman, Lewis R.
[J]. LEUKEMIA RESEARCH, 2018, 64 : 10 - 16
[4] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
Steensma, D.
Abedi, M.
Bejar, R.
Cogle, C.
Foucar, K.
Garcia-Manero, G.
George, T.
Grinblatt, D.
Komrokji, R.
Maciejewski, J.
Pollyea, D.
Roboz, G.
Savona, M.
Scott, B.
Sekeres, M.
Thompson, M.
Sugrue, M.
Swern, A.
Nifenecker, M.
Erba, H.
[J]. LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
[5] ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS): EFFECTS IN TREATMENT NAIVE AND RELAPSED/REFRACTORY PATIENTS
Navada, S.
Garcia-Manero, G.
Hearn, K.
Odchimar-Reissig, R.
Demakos, E.
Fenaux, P.
Petrone, M.
Zbyszewski, P.
Fruchtman, S.
Silverman, L.
[J]. HAEMATOLOGICA, 2017, 102 : 183 - 184
[6] Rigosertib activity in patients with a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) relapsed or refractory to hypomethylating agents
Navada, S. C.
Odchimar-Reissig, R.
Reddy, E. P.
Demakos, E. P.
Holland, J. F.
Wilhelm, F.
Silverman, L. R.
[J]. LEUKEMIA RESEARCH, 2013, 37 : S146 - S146
[7] Population pharmacokinetic modelling of decitabine in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Mistry, B.
Gibiansky, L.
Hussein, Z.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[8] End of Life (EOL) Metrics in Older Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
LoCastro, M.
Baran, A. M.
Liesveld, J.
Becker, M. W.
O'Dwyer, K. M.
Husehon, E.
Aljitawi, O. S.
Baumgart, M.
Snyder, E.
Kluger, B.
Mendler, J. H.
Loh, K.
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S285 - S285
[9] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
ANDREEFF, M
STONE, R
YOUNG, C
TONG, W
ERVIN, T
TAFURI, A
KOLITZ, J
RIFKIND, R
KUFE, D
MARKS, P
[J]. LEUKEMIA, 1991, 5 (02) : 174 - 174
[10] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
Padmanabhan, A.
Block, A.
Sait, S.
Ford, L. A.
O'Connor, T. L.
Moysich, K. B.
Baer, M. R.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)

← 1 2 3 4 5 →